Targeting non-conserved cysteines for allosteric inhibition of SHP2

被引：0
|
作者：
Kao, Lynn [1 ]
Kim, Jenny [1 ]
Bishop, Anthony [2 ]
机构：
[1] Amherst Coll, Amherst, MA 01002 USA
[2] Amherst Coll, Dept Chem, Amherst, MA 01002 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2019年 / 258卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
225
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Allosteric inhibition of SHP2 phosphatase
    Fortanet, Jorge Garcia
    Chen, Christine
    Chen, Yingnan
    Chen, Zhouliang
    Deng, Zhan
    Firestone, Brant
    Fekkes, Peter
    Fodor, Michelle
    Fortin, Pascal
    Fridrich, Cary
    Grunenfelder, Denise
    Ho, Samuel
    Kang, Zhao
    Karki, Rajesh
    Kato, Mitsunori
    Keen, Nick
    Labonte, Laura
    Larrow, Jay
    Lenoir, Francois
    Liu, Gang
    Liu, Shumei
    Lombardo, Franco
    Majumdar, Dyuti
    Meyer, Matthew
    Palermo, Mark
    Perez, Lawrence
    Pu, Minying
    Ramsey, Timothy
    Sellers, William
    Shultz, Michael
    Stams, Travis
    Towler, Chris
    Wang, Ping
    Williams, Sarah
    Zhang, Ji-Hu
    LaMarche, Matthew
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [2] Dual Allosteric Inhibition of SHP2 Phosphatase
    Fodor, Michelle
    Price, Edmund
    Wang, Ping
    Lu, Hengyu
    Argintaru, Andreea
    Chen, Zhouliang
    Glick, Meir
    Hao, Huai-Xiang
    Kato, Mitsunori
    Koenig, Robert
    LaRochelle, Jonathan R.
    Liu, Gang
    McNeill, Eric
    Majumdar, Dyuti
    Nishiguchi, Gisele A.
    Perez, Lawrence B.
    Paris, Gregory
    Quinn, Christopher M.
    Ramsey, Timothy
    Sendzik, Martin
    Shultz, Michael David
    Williams, Sarah L.
    Stams, Travis
    Blacklow, Stephen C.
    Acker, Michael G.
    LaMarche, Matthew J.
    ACS CHEMICAL BIOLOGY, 2018, 13 (03) : 647 - 656
  • [3] Destabilization of the SHP2 and SHP1 protein tyrosine phosphatase domains by a non-conserved "backdoor" cysteine
    Yarnall, Matthew T. N.
    Kim, Sean H.
    Korntner, Samuel
    Bishop, Anthony C.
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2022, 32
  • [4] Targeting a Cryptic Allosteric Site for Selective Inhibition of the Oncogenic Protein Tyrosine Phosphatase Shp2
    Chio, Cynthia M.
    Lim, Christopher S.
    Bishop, Anthony C.
    BIOCHEMISTRY, 2015, 54 (02) : 497 - 504
  • [5] Identifying a non-conserved site for achieving allosteric covalent inhibition of CECR2
    Tang, Cai-ling
    Li, Yuan-qing
    Du, Xi-kun
    Fang, Xiao-xia
    Guang, Yi-man
    Li, Pei-zhuo
    Chen, Shuang
    Xue, Sheng-yu
    Yu, Jia-min
    Liu, Xiao-yi
    Luo, Yi-pan
    Zhou, Lan-xin
    Luo, Cheng
    Xiong, Huan
    Liang, Zhong-jie
    Ding, Hong
    ACTA PHARMACOLOGICA SINICA, 2025,
  • [6] Simultaneous inhibition of SHP2 phosphatase at two allosteric sites
    Fodor, Michelle
    Price, Edmund
    Wang, Ping
    Lu, Hengyu
    Argintaru, Andreea
    Chen, Zhouliang
    Glick, Meir
    Hao, Huai-Xiang
    Kato, Mitsunori
    Koenig, Robert
    LaRochelle, Jonathan R.
    Liu, Gang
    McNeill, Eric
    Majumdar, Dyuti
    Nishiguchi, Gisele
    Perez, Lawrence
    Paris, Greg
    Quinn, Christopher
    Ramsey, Timothy
    Sendzik, Martin
    Shultz, Michael
    Williams, Sarah
    Stams, Travis
    Blacklow, Stephen C.
    LaMarche, Matthew J.
    Acker, Michael G.
    CANCER RESEARCH, 2018, 78 (13)
  • [7] Allosteric SHP2 phosphatase inhibition: Multiple mechanisms and chemotypes
    LaMarche, Matthew J.
    Bagdanoff, Jeff
    Acker, Mike
    Chen, Ying-Nan
    Chan, Homan
    Dore, Michael
    Firestone, Brant
    Fodor, Michelle
    Garcia-Fortanet, Jorge
    Hentemann, Murphy
    Kato, Mitsunori
    Koenig, Robert
    La Bonte, Laura
    Liu, Shumei
    Mohseni, Movarid
    Ntaganda, Rukundo
    Sarver, Patrick
    Smith, Troy
    Sendzik, Martin
    Stams, Travis
    Spence, Stan
    Towler, Chris
    Wang, Hongyun
    Wang, Ping
    Williams, Sarah
    Chen, Zhouliang
    Hao, Huaixiang
    Liu, Gang
    Liu, Chen
    McNeill, Eric
    Yu, Bing
    CANCER RESEARCH, 2019, 79 (13)
  • [8] Targeting SHP2 Cryptic Allosteric Sites for Effective Cancer Therapy
    Rehman, Ashfaq Ur
    Zhao, Cizhang
    Wu, Yongxian
    Zhu, Qiang
    Luo, Ray
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [9] FGFR- and EGFR-driven SHP2 activation displays differential sensitivity to allosteric SHP2 inhibition
    Hao, Huaixiang
    Lu, Hengyu
    Liu, Chen
    LaMarche, Matthew
    Engelman, Jeffrey A.
    Hammerman, Peter S.
    Caponigro, Giordano
    CANCER RESEARCH, 2019, 79 (13)
  • [10] Exploring the cause of the dual allosteric targeted inhibition attaching to allosteric sites enhancing SHP2 inhibition
    Ma Yangchun
    Yang WenYu
    Zhou Liang
    Li LiPeng
    Wu JingWei
    Li WeiYa
    Du Shan
    Ma Ying
    Wang RunLing
    Molecular Diversity, 2022, 26 : 1567 - 1580
12345